- call +1-201-465-4211
- email sales@mrinsights.biz
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
Scope of the Report:
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
North Americas is the largest consumption place, with a revenue market share nearly 44.8% in 2018. Following North Americas, Europe is the second largest consumption place with the revenue market share of 29% in 2018.
The worldwide market for Therapeutic Nuclear Medicines is expected to grow at a CAGR of roughly 17.2% over the next five years, will reach 1947.5 million US$ in 2024, from 879.8 million US$ in 2019.
This report focuses on the Therapeutic Nuclear Medicines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bayer
Novartis AG
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Radium-223
Lutetium-177
Iodine-131
Other
Market Segment by Applications, can be divided into
Thyroid
Bone Metastasis
Lymphoma
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Therapeutic Nuclear Medicines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Therapeutic Nuclear Medicines, with price, sales, revenue and global market share of Therapeutic Nuclear Medicines in 2017 and 2018.
Chapter 3, the Therapeutic Nuclear Medicines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Therapeutic Nuclear Medicines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Therapeutic Nuclear Medicines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Therapeutic Nuclear Medicines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Therapeutic Nuclear Medicines Introduction
1.2 Market Analysis by Type
1.2.1 Radium-223
1.2.2 Lutetium-177
1.2.3 Iodine-131
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 Thyroid
1.3.2 Bone Metastasis
1.3.3 Lymphoma
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Therapeutic Nuclear Medicines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novartis AG
2.2.1 Business Overview
2.2.2 Therapeutic Nuclear Medicines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis AG Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 China Isotope & Radiation
2.3.1 Business Overview
2.3.2 Therapeutic Nuclear Medicines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Dongcheng
2.4.1 Business Overview
2.4.2 Therapeutic Nuclear Medicines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Dongcheng Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Q BioMed
2.5.1 Business Overview
2.5.2 Therapeutic Nuclear Medicines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Q BioMed Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Curium Pharmaceuticals
2.6.1 Business Overview
2.6.2 Therapeutic Nuclear Medicines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Jubilant DraxImage
2.7.1 Business Overview
2.7.2 Therapeutic Nuclear Medicines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Lantheus
2.8.1 Business Overview
2.8.2 Therapeutic Nuclear Medicines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Spectrum Pharmaceuticals
2.9.1 Business Overview
2.9.2 Therapeutic Nuclear Medicines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Progenics Pharmaceuticals
2.10.1 Business Overview
2.10.2 Therapeutic Nuclear Medicines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 International Isotopes
2.11.1 Business Overview
2.11.2 Therapeutic Nuclear Medicines Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Therapeutic Nuclear Medicines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Therapeutic Nuclear Medicines Manufacturer Market Share in 2018
3.3.2 Top 6 Therapeutic Nuclear Medicines Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Therapeutic Nuclear Medicines Market Analysis by Regions
4.1 Global Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Regions
4.1.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Regions (2014-2019)
4.1.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Regions (2014-2019)
4.2 North America Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
4.3 Europe Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
4.5 South America Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
5 North America Therapeutic Nuclear Medicines by Country
5.1 North America Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
5.1.1 North America Therapeutic Nuclear Medicines Sales and Market Share by Country (2014-2019)
5.1.2 North America Therapeutic Nuclear Medicines Revenue and Market Share by Country (2014-2019)
5.2 United States Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
5.3 Canada Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
5.4 Mexico Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
6 Europe Therapeutic Nuclear Medicines by Country
6.1 Europe Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
6.1.1 Europe Therapeutic Nuclear Medicines Sales and Market Share by Country (2014-2019)
6.1.2 Europe Therapeutic Nuclear Medicines Revenue and Market Share by Country (2014-2019)
6.2 Germany Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
6.3 UK Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
6.4 France Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
6.5 Russia Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
6.6 Italy Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
7 Asia-Pacific Therapeutic Nuclear Medicines by Country
7.1 Asia-Pacific Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Therapeutic Nuclear Medicines Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue and Market Share by Country (2014-2019)
7.2 China Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
7.3 Japan Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
7.4 Korea Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
7.5 India Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
8 South America Therapeutic Nuclear Medicines by Country
8.1 South America Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
8.1.1 South America Therapeutic Nuclear Medicines Sales and Market Share by Country (2014-2019)
8.1.2 South America Therapeutic Nuclear Medicines Revenue and Market Share by Country (2014-2019)
8.2 Brazil Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
8.3 Argentina Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
8.4 Colombia Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
9 Middle East and Africa Therapeutic Nuclear Medicines by Countries
9.1 Middle East and Africa Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Therapeutic Nuclear Medicines Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
9.3 Turkey Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
9.4 Egypt Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
9.5 Nigeria Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
9.6 South Africa Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
10 Global Therapeutic Nuclear Medicines Market Segment by Type
10.1 Global Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Type (2014-2019)
10.1.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2014-2019)
10.2 Radium-223 Sales Growth and Price
10.2.1 Global Radium-223 Sales Growth (2014-2019)
10.2.2 Global Radium-223 Price (2014-2019)
10.3 Lutetium-177 Sales Growth and Price
10.3.1 Global Lutetium-177 Sales Growth (2014-2019)
10.3.2 Global Lutetium-177 Price (2014-2019)
10.4 Iodine-131 Sales Growth and Price
10.4.1 Global Iodine-131 Sales Growth (2014-2019)
10.4.2 Global Iodine-131 Price (2014-2019)
10.5 Other Sales Growth and Price
10.5.1 Global Other Sales Growth (2014-2019)
10.5.2 Global Other Price (2014-2019)
11 Global Therapeutic Nuclear Medicines Market Segment by Application
11.1 Global Therapeutic Nuclear Medicines Sales Market Share by Application (2014-2019)
11.2 Thyroid Sales Growth (2014-2019)
11.3 Bone Metastasis Sales Growth (2014-2019)
11.4 Lymphoma Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Therapeutic Nuclear Medicines Market Forecast (2019-2024)
12.1 Global Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate (2019-2024)
12.2 Therapeutic Nuclear Medicines Market Forecast by Regions (2019-2024)
12.2.1 North America Therapeutic Nuclear Medicines Market Forecast (2019-2024)
12.2.2 Europe Therapeutic Nuclear Medicines Market Forecast (2019-2024)
12.2.3 Asia-Pacific Therapeutic Nuclear Medicines Market Forecast (2019-2024)
12.2.4 South America Therapeutic Nuclear Medicines Market Forecast (2019-2024)
12.2.5 Middle East and Africa Therapeutic Nuclear Medicines Market Forecast (2019-2024)
12.3 Therapeutic Nuclear Medicines Market Forecast by Type (2019-2024)
12.3.1 Global Therapeutic Nuclear Medicines Sales Forecast by Type (2019-2024)
12.3.2 Global Therapeutic Nuclear Medicines Market Share Forecast by Type (2019-2024)
12.4 Therapeutic Nuclear Medicines Market Forecast by Application (2019-2024)
12.4.1 Global Therapeutic Nuclear Medicines Sales Forecast by Application (2019-2024)
12.4.2 Global Therapeutic Nuclear Medicines Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Therapeutic Nuclear Medicines Picture
Table Product Specifications of Therapeutic Nuclear Medicines
Figure Global Sales Market Share of Therapeutic Nuclear Medicines
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
